What is organizing pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Organizing Pneumonia?

Organizing pneumonia (OP) is a specific pattern of lung injury characterized by plugs of granulation tissue (fibroblasts and myofibroblasts in loose connective matrix) filling the alveolar ducts and alveoli, with or without bronchiolar involvement, representing a reversible inflammatory response rather than true infection. 1, 2

Definition and Classification

Organizing pneumonia is classified as an interstitial lung disease and represents a histopathologic pattern rather than a single disease entity 3. The term "organizing pneumonia" has replaced the older terminology "bronchiolitis obliterans organizing pneumonia (BOOP)" 4, 5.

Two main categories exist:

  • Cryptogenic Organizing Pneumonia (COP): Idiopathic form when no underlying cause is identified, accounting for approximately 5-10% of idiopathic interstitial pneumonias 1, 6
  • Secondary Organizing Pneumonia (SOP): Associated with identifiable causes including:
    • Infections (including COVID-19 as a notable recent association) 3, 7
    • Drug toxicity 8
    • Connective tissue diseases (rheumatoid arthritis, polymyositis, antisynthetase syndrome) 1, 8
    • Radiation therapy 8
    • Organ transplantation 3
    • Inhalation injuries 3
    • Malignancy 8

Clinical Presentation

Patients typically present with a subacute illness of relatively short duration (median less than 3 months) following a flu-like prodrome 1, 5. Key features include:

  • Respiratory symptoms: Dry cough and progressive dyspnea 6
  • Constitutional symptoms: Fever, fatigue, and weight loss are common 5, 6
  • Physical examination: May be normal or reveal inspiratory crackles 5
  • Hypoxemia: Can occur at rest or with exertion 5
  • Age: Average diagnosis between 50-60 years 6

Radiologic Features

HRCT characteristically demonstrates patchy and often migratory consolidation in a subpleural, peribronchial, or bandlike pattern, commonly associated with ground-glass opacity 1.

Three main imaging patterns exist:

  1. Typical pattern: Multiple patchy alveolar opacities (most common) 2
  2. Focal pattern: Solitary nodule or mass 2
  3. Diffuse pattern: Diffuse infiltrative opacities 2

Specific helpful radiologic signs include:

  • Perilobular opacities 1
  • Reversed halo sign (atoll sign) - a central ground-glass opacity surrounded by denser consolidation 1, 2
  • Small unilateral or bilateral pleural effusions (10-30% of patients) 1
  • Localized consolidations typically subpleural or in lower zones 6

Histopathology

The defining histologic feature is patchy filling of alveolar ducts and alveoli by loose plugs of connective tissue (buds of granulation tissue) 2, 9. The process results from a sequence of alveolar injury, fibrin deposition, and colonization by proliferating fibroblasts 2. Some cases show marked interstitial inflammation overlapping with cellular nonspecific interstitial pneumonia (NSIP) 1.

Prognosis and Treatment Response

The majority of patients recover completely with oral corticosteroids, which is a defining feature of the disease 1, 5. However, several important caveats exist:

  • Relapse is common (25-50%), typically occurring during steroid taper or after withdrawal 1, 5
  • Prolonged corticosteroid courses (6-12 months) are recommended 5
  • A minority of patients develop progressive interstitial fibrosis despite treatment, with residual or recurrent episodes 1
  • Prognosis in COP is generally excellent; in SOP it depends on the underlying cause 9

Critical Diagnostic Distinction

A crucial clinical point: OP requires corticosteroids, not antimicrobials 3. This is particularly important in post-COVID-19 patients with atypical chest imaging, where OP should be considered as a complication rather than bacterial superinfection 3, 7.

The fundamental challenge in understanding OP lies in differentiating this reversible process from irreversible fibrosis (as seen in usual interstitial pneumonia/IPF), as this distinction determines vastly different outcomes 2.

References

Research

Cryptogenic organizing pneumonia.

Seminars in respiratory and critical care medicine, 2012

Research

A review of organizing pneumonia.

JAAPA : official journal of the American Academy of Physician Assistants, 2023

Research

Cryptogenic Organizing Pneumonia.

Seminars in respiratory and critical care medicine, 2025

Research

ORGANIZING PNEUMONIA: AN UNUSUAL SEQUELA OF COVID-19 INFECTION.

European journal of case reports in internal medicine, 2023

Research

Clinico-etiological characteristics of organizing pneumonia: A retrospective study.

Lung India : official organ of Indian Chest Society, 2021

Research

Organizing pneumonia.

The American journal of the medical sciences, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.